Story perspectives

FDA's Makary Celebrates Year of Faster Approvals and Innovations

4/2/2026

Summary

Story summary

Marty Makary, FDA Commissioner, marked one year in office by citing improvements in medication approvals.
He noted faster review times and the integration of artificial intelligence tools.
Addressing staff reductions under the Department of Government Efficiency, he said many affected employees were reinstated.
The FDA approved Eli Lilly's weight-loss pill Foundayo, to be available soon.
A study linked certain chemicals in plastics to newborn deaths and premature births.

1 of 1

Story summary

Marty Makary, FDA Commissioner, marked one year in office by citing improvements in medication approvals.
He noted faster review times and the integration of artificial intelligence tools.
Addressing staff reductions under the Department of Government Efficiency, he said many affected employees were reinstated.
The FDA approved Eli Lilly's weight-loss pill Foundayo, to be available soon.
A study linked certain chemicals in plastics to newborn deaths and premature births.